期刊文献+

淀粉样变性病的发病机制及治疗前景 被引量:10

原文传递
导出
摘要 淀粉样变性病是一组因特殊蛋白质在细胞外形成不可溶的具有β样折叠结构的纤维丝沉积,从而引起器官功能障碍的疾病。经刚果红染色后淀粉样物质在光镜下表现为砖红色,偏振光显微镜下表现为双折光苹果绿色,电子显微镜下见直径8~10nm的排列紊乱的无分支的纤维丝结构。淀粉样变性病可累及全身各个器官,临床上表现为系统性淀粉样变性病或局部淀粉样变性病。在不同国家、种族间疾病类型亦不相同,但大都严重影响患者的生活质量。故加深对其发病机制的认识,将为治疗提供更多新的选择。
出处 《中华内科杂志》 CAS CSCD 北大核心 2008年第2期165-167,共3页 Chinese Journal of Internal Medicine
  • 相关文献

参考文献23

  • 1Sipe JD, Cohen AS. Review: History of the amyloid fibril. J Struct Biol,2000,130:88-98.
  • 2Brunt EM,Tiniakos DG. Metabolic storage diseases: amyloidosis.Clin Liver Dis, 2004, 8: 915-930,x.
  • 3Dember LM. Amyloidosis-associated kidney disease. J Am Soc Nephrol, 2006, 17:3458-3471.
  • 4Perfetti V, Palladini G,Merlini G, et al. Immune mechanisms of AL amyloidosis. Drug Discovery Today: Disease Mechanisms, 2004, 1 : 365-373.
  • 5Merlin; G, Westermark P. The systemic amyloidoses: clearer understanding of the molecular mechanisms offers hope for more effective therapies. J Intern Med ,2004,255 : 159-178.
  • 6谌贻璞.要更新对淀粉样变肾病的认识[J].中华肾脏病杂志,2007,23(6):343-344. 被引量:7
  • 7Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med, 2003, 349: 583-596.
  • 8Ghiso J, Frangione B. Amyloidosis and Alzheimer's disease. Adv Drug Deliv Rev ,2002,54 : 1539-1551.
  • 9Maynard CJ, Cappai R, Volitakis I, et al. Overexpression of Alzheimer's disease amyloid-beta opposes the age-dependent elevations of brain copper and iron. J Biol Chem, 2002, 277 : 44670-44676.
  • 10Miura T, Mitani S, Takanashi C, et al. Copper selectively triggers beta-sheet assembly of an N-terminally truncated amyloid betapeptide beginning with Glu3. J Inorg Biochem,2004,98:10-14.

二级参考文献8

  • 1Picken MM. New insights into systemic amyloidosis: the importance of diagnosis of specific type. Curr Opin Nephrol Hypertens, 2007, 16:196-203.
  • 2Dember LM. Amyloidosis-associated kidney disease. J Am Soc Nephrol, 2006, 17:3458-3471.
  • 3Picken MM. Immunoglobulin light and heavy chain amyloidosis AL/AH: renal pathology and differential diagnosis. Contrib Nephrol, 2007, 153 : 135-155.
  • 4Comenzo RL. Amyloidosis. Curr Treat Options Oncol, 2006, 7:225-236.
  • 5Palladini G, Perfetti V, Merlini G. Therapy and management of systemic AL (primary) amyloidosis. Swiss Med Wkly, 2006, 136:715-720.
  • 6Comenzo RL. Current and emerging views and treatments of systemic immunoglobulin light-chain (Al) amyloidosis. Contrib Nephrol, 2007, 153:195-210.
  • 7Dember L, Lachmann H, Obici L, et al. Eprodisate (NC- 503) treatment of AA amyloidosis: Open label follow-up of a randomized controlled trail. J Am Soc Nephrol, 2006, 17: 566A.
  • 8Berk J, Bisbee J, Kelly J, et al. Clinical trail for TTR amyloidosis using diflunisal. Amyloid, 2006, 13 Suppl 1: 11A.

共引文献6

同被引文献75

  • 1刘刚,邹万忠.肾淀粉样变性病的早期诊断[J].中华内科杂志,2005,44(3):234-234. 被引量:14
  • 2荻原正大,李胜.肾淀粉样变性的治疗[J].日本医学介绍,2005,26(9):405-407. 被引量:6
  • 3陈惠萍.肾淀粉样变性病理诊断的体会[J].肾脏病与透析肾移植杂志,2005,14(5):433-435. 被引量:16
  • 4王天彬.肾淀粉样变性漏诊三例分析[J].临床误诊误治,2006,19(1):50-50. 被引量:3
  • 5王海燕.肾脏病学[M].北京:人民卫生出版社,2008:1948-1949.
  • 6Kelkitli E, Bilgici B,Tokgoz B, et al. SAA1 alpha/alpha alleles in amyloidosis[J]. Nephrol, 2006,19 (10) :189-191.
  • 7Picken MM. New insights into systemic amyloidosis: the importance of diagnosis of specific type[J]. Curt Opin Nephrol Hy,2007,16(3):196-203.
  • 8December LM. Amyloidosis-associated kidney disease[J]. Am Soc Nephol, 2006,17(12) : 3458-3471.
  • 9McMahan ZH,Sailors JL, Toto T, et al. Systemic amyloidosis presenting as chronic diarrhea in a patient with ankylosing spondylitis[J]. Clin Rheumatol, 2010,16 ( 1 ) : 22 -25.
  • 10Sattianayagam PT, Hawkins PN, Gillmore JD. Systemic amyloidosis and the gastrointestinal tract [J ]. Nat Rev Gastroent Hepatol,2009,6(10) :608-617.

引证文献10

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部